MUMBAI, India, Aug. 17 -- Intellectual Property India has published a patent application (202627032895 A) filed by Universiteit Twente on March 18, 2026, for Glycogen For Supporting Tissue Viability.
Inventors include Gurian, Melvin; Leijten, Jeroen Christianus Hermanus; Allijn, Iris Eva; Porsul, Isa Robin; and Willemen, Niels Godefridus Andreas.
The application for the patent was published on August 14, 2026, under issue no. 33/2026.
Abstract: The present invention relates to use of glycogen for maintaining viability of non-perfused tissue or sub-optimally perfused tissue, for increasing survival time of a non- perfused or sub-optimally perfused tissue structure, for preventing necrotic core formation in a non-perfused or sub-optimally perfused tissue structure, and/or for increasing production of angiogenic growth factors by non-perfused or sub-optimally perfused tissue. Also foreseen is the use of glycogen in the prevention of tissue implant rejection in a patient, or in the treatment of a tissue pathology in a patient wherein the glycogen may be in combination with replacement tissue and/or scaffold for tissue ingrowth.
Disclaimer: Curated by HT Syndication.
